摘要Objective:To explore the relationship of plasma levels of LP-PLA2, GMP, LPA and platelet activation markers with transient ischemic attack(TIA).Methods:A total of 87 cases with TIA were collected, and all patients were treated with ozagrel (120mg/times/day for 2 weeks). Fasting blood were collected in 24 h after attack and 7d, 14 days after treatment respectively, then flow cytometry was used to detect indicators of platelet activation, such as CD63, PAC-1, GPⅡb /Ⅲa, and the plasma levels of LP-PLA2, GMP, LPA. The dynamic changes of the such indexes and the differences between different populations were analyzed.Results:The plasma levels of LP-PLA2, GMP, LPA and the platelet activation indexes including CD63, PAC-1, GPⅡb/Ⅲa of patients with TIA were all significantly higher than control group (allP<0.05). One day after treatment of sodium Ozagrel, the plasma levels of LP-PLA2, GMP, LPA and the platelet activation indexes such as CD63, PAC-1, GPⅡb/Ⅲa of patients with TIA began to decline, and returned to normal in the treatment of 7 d or 14 d.Conclusions:Platelet activation plays an important role in the occurrence of TIA, and antiplatelet therapy can effectively inhibit platelet activation, which has positive significance in the treatment of TIA.